Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06367699 · ClinicalTrials.gov registry record · NA
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial
A NA study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT06367699: Clinical Trial NA study, sponsored by Tufts Medical Center.
NCT06367699 is a NA study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06367699, a NA study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
Primary Outcome
HPV vaccination series completion for the control group will be compared to the collective rate for the intervention groups. A review of medical records at the T2 timepoint will be done for vaccination series completion.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL ECA-HPV App with Clinic Notification and Adolescent Functions Disabled
- BEHAVIORAL ECA-HPV App with Clinic Notification Function Enabled
- BEHAVIORAL ECA-HPV App with Adolescent Function Enabled
- BEHAVIORAL ECA-HPV App with Clinic Notification and Adolescent Functions Enabled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Why NCT06367699 stopped before completion
NCT06367699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Usual Care is the first listed.
NCT06367699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06367699 about?
NCT06367699 is a clinical study titled "Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial". The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
What is the current status of trial NCT06367699?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2024-11-13. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06367699?
The interventions under investigation include: Usual Care (BEHAVIORAL), ECA-HPV App with Clinic Notification and Adolescent Functions Disabled (BEHAVIORAL), ECA-HPV App with Clinic Notification Function Enabled (BEHAVIORAL), ECA-HPV App with Adolescent Function Enabled (BEHAVIORAL), ECA-HPV App with Clinic Notification and Adolescent Functions Enabled (BEHAVIORAL).
Who is sponsoring clinical trial NCT06367699?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06367699's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI